Who will Benefit from a Wide-Scale Introduction of Vaginal Microbicides in Developing Countries?
about
Analytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectivenessHow Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health ImpactPopulation-level benefits from providing effective HIV prevention means to pregnant women in high prevalence settingsWhat do mathematical models tell us about the emergence and spread of drug-resistant HIV?Modeling the gender-specific impact of vaginal microbicides on HIV transmission.The future role of rectal and vaginal microbicides to prevent HIV infection in heterosexual populations: implications for product development and preventionMathematical insights in evaluating state dependent effectiveness of HIV prevention interventions.Are Clade Specific HIV Vaccines a Necessity? An Analysis Based on Mathematical Models.Beating the placebo in HIV prevention efficacy trials: the role of the minimal efficacy bound.Impact of Pill Sharing on Drug Resistance Due to a Wide-Scale Oral Prep Intervention in Generalized Epidemics.Impact of Population Recruitment on the HIV Epidemics and the Effectiveness of HIV Prevention InterventionsProjected effectiveness and added value of HIV vaccination campaigns in South Africa: A modeling study.
P2860
Q28535414-3EC6A091-5D5C-4E5F-8BDB-A9C167140D01Q28552455-BE2CD8EE-6B67-45D3-A578-B90D54EA5633Q29109917-7CA79D36-A0C6-4831-8E94-B02E29B324CBQ34989198-25185A60-82F8-4CC8-BC3C-4EEE3E32716AQ35252598-97D5B672-1368-4B5C-96ED-D2B3052408ECQ35903632-82A318AA-5728-468E-B4E4-E1D431084BC2Q36274199-48B510C7-CA7B-4F8A-AECC-784E122CD3F6Q36437672-F2317668-D421-4A9F-90D8-D4A544DE1CFCQ36487437-8CADE476-7DCA-4EA4-B410-E9097B1BEDD4Q37409926-3ED0E85F-CA67-4AD3-B054-2BF124506103Q39321915-F4FABCAA-BDDB-4A14-8CCB-D040D452C52CQ54233736-5C798FDA-CCDA-4179-99A0-F27420BEC066
P2860
Who will Benefit from a Wide-Scale Introduction of Vaginal Microbicides in Developing Countries?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Who will Benefit from a Wide-S ...... cides in Developing Countries?
@en
Who will Benefit from a Wide-S ...... cides in Developing Countries?
@nl
type
label
Who will Benefit from a Wide-S ...... cides in Developing Countries?
@en
Who will Benefit from a Wide-S ...... cides in Developing Countries?
@nl
prefLabel
Who will Benefit from a Wide-S ...... cides in Developing Countries?
@en
Who will Benefit from a Wide-S ...... cides in Developing Countries?
@nl
P2093
P2860
P356
P1476
Who will Benefit from a Wide-S ...... cides in Developing Countries?
@en
P2093
Benoit Masse
Dobromir T Dimitrov
Marie-Claude Boily
P2860
P356
10.2202/1948-4690.1012
P577
2010-01-01T00:00:00Z